Bacillus Calmette-Guerin in the treatment of neoplastic disease.

Laucius Jf, Bodurtha Aj, Mastrangelo Mj, +1

PubMed

Bacillus Calmette-guerinSurgical PathologyPathogenesisPathologyMolecular Pathology +2

Radiation therapy in small cell lung cancer.

Seydel Hg, Creech Rh, William Mietlowski, +1

PubMed

Radiation MedicineRadiation TherapyMedicineOncologyRadiation Oncology +1

Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial.

Slayton Re, Michele Pagano, Creech Rh

PubMed

Gynecological SurgeryAdvanced Ovarian CancerMedicineIntramuscular InjectionGynecology +9

Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.

Bellet Re, Engstrom Pf, Catalano Rb, +2

PubMed

Gastrointestinal OncologyMedicineMetastatic Colorectal CarcinomaColorectal CancerPathology +5

Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).

Creech Rh, David Tritchler, Ettinger Ds, +4

PubMed

PathologyPhase Ii StudyPharmacotherapyMetronomic ChemotherapyTumor Biology +15

Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agents.

Gelman Rs, Tormey Dc, Rebecca A. Betensky, +5

PubMed

Breast OncologyOncologySurface AreaChemotherapy AgentsMetronomic Therapy +10

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).

Ruckdeschel Jc, R. Day, Weissman Ch, +2

PubMed

Surgical OncologyPathologyPharmacotherapyEcog Performance StatusCancer Chemotherapy +18

The psychologic support of the cancer patient: a medical oncologist's viewpoint.

Creech Rh

PubMed

Phase II study of low-dose mitomycin in patients with ovarian cancer previously treated with chemotherapy.

Creech Rh, Shah Mk, Catalano Rb, +3

PubMed

Hematological MalignancyForty-three Evaluable PatientsMedicineLow-dose MitomycinChemotherapy +13

Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).

Creech Rh, K. Stanley, Vogl Se, +2

PubMed

Est 2578Tumor BiologyMedicineSeventy-three PatientsPharmacology +11